rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Kelvin Neu

Director

Company insider

Files Form 4 as: Director, Zymeworks; Director, Zymeworks; Director, Xoma.

In numbers

Trades disclosed
10
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
3
Companies where not an officer
3
First trade
19 Jul 2012
Last trade
12 Jan 2026
Last filed
12 Jan 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
ZYME ZymeworksDirector · Biotechnology · last 12 Jan 20260 buys · 0 sells
ZymeworksDirector · last 6 May 20210 buys · 0 sells
XomaDirector · last 19 Jul 20120 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
12 Jan 2026filed 12 Jan 2026ZYME Zymeworksoption or derivative · BiotechnologySEC FORM 4 Code A—11,500 at $0.00filing
12 Jan 2026filed 12 Jan 2026ZYME Zymeworksoption or derivative · BiotechnologySEC FORM 4 Code A—7,700 at $0.00filing
12 Jan 2026filed 12 Jan 2026ZYME Zymeworksoption or derivative · BiotechnologySEC FORM 4 Code A—11,500 at $0.00filing
12 Jan 2026filed 12 Jan 2026ZYME Zymeworksoption or derivative · BiotechnologySEC FORM 4 Code A—7,700 at $0.00filing
10 Dec 2024filed 12 Dec 2024ZYME Zymeworksoption or derivative · BiotechnologySEC FORM 4 Code A—31,000 at $0.00filing
7 Dec 2023filed 8 Dec 2023ZYME Zymeworksoption or derivative · BiotechnologySEC FORM 4 Code A—37,000 at $0.00filing
21 Dec 2022filed 23 Dec 2022ZYME Zymeworksoption or derivative · BiotechnologySEC FORM 4 Code A—25,000 at $0.00filing
6 May 2021filed 7 May 2021Zymeworksoption or derivativeSEC FORM 4 Code A—9,000 at $0.00filing
19 Jul 2012filed 23 Jul 2012Xomaoption or derivativeSEC FORM 4 Code A$82K23,200 at $3.53filing
19 Jul 2012filed 23 Jul 2012XomaSEC FORM 4 Code A—16,800 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Adam SchayowitzEVP, Head of R&D · EVP, Head of R&D at Zymeworks, filing Form 4 there in the last year
Mark HollywoodEVP & Chief Operating Officer · EVP & Chief Operating Officer at Zymeworks, filing Form 4 there in the last year
Paul R. SchneiderEVP, General Counsel · EVP, General Counsel at Zymeworks, filing Form 4 there in the last year
Scott PlatshonEVP, Chief Business Officer · EVP, Chief Business Officer at Zymeworks, filing Form 4 there in the last year
Kristin StaffordDirector · EVP, Chief Financial Officer at Zymeworks, filing Form 4 there in the last year